Author

Wen Chean Lim

Observed name: Wen-Chean Lim

Institution: Autolus (United Kingdom)

Observed institutions: Autolus (United Kingdom), University of Southampton

ORCID: 0000-0002-0954-7593

Observed ORCID: 0000-0002-0954-7593

OpenAlex ID: A5022497270

Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

2023 · Lydia Lee, Wen Chean Lim, et al. · Journal for ImmunoTherapy of Cancer · 49

Human Endothelial Cells Modulate CD4+ T Cell Populations and Enhance Regulatory T Cell Suppressive Capacity

2018 · Wen Chean Lim, Michael Olding, et al. · Frontiers in Immunology · 49

Microwave therapy for cutaneous human papilloma virus infection

2017 · Ivan Bristow, Wen Chean Lim, et al. · European Journal of Dermatology · 32

Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies

2024 · Mathieu Ferrari, Matteo Righi, et al. · Nature Communications · 26

Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2

2023 · Julia Taylor, Anna Bulek, et al. · Frontiers in Immunology · 9

A Dominant Negative SHP-2 Which Abrogates PD-1 Signalling Pathways and Restores Function of Cytotoxic CAR T Cells

2017 · Vania Baldan, Priyanka Ghongane, et al. · Blood · 5

Development of a Phase 1 Study Evaluating the Activity of Modular CAR T for Multiple Myeloma (MCARTY) Targeting BCMA and CD19 for Improved Persistence

2023 · Lydia Sarah Hui Lee, Wen Chean Lim, et al. · Blood · 3

Activation of regulatory T cells by endothelial cells in inflammatory skin disease

2015 · Wen Chean Lim · ePrints Soton (University of Southampton)

Works count: 8

Citation count: 173

H-index: 5

I10-index: 4